Low-carb, low-fibre diets could raise risks of colon cancer – Toronto Star
Numerous studies have shown that a diet high in sugar and fat — a so-called “Western-style diet” — is linked to colorectal cancer, as well as obesity …
Targeted drug offers hope for safe, effective senolytic treatment for liver disease, cancer
… obesity and diabetes in the region. This chronic liver condition can lead to serious health conditions including severe liver fibrosis or …
Tesla, Broadcom, Strategy, Coinbase, Robinhood: Stocks to watch today – Quartz
Eli Lilly wants to replace Zepbound with an even stronger weight loss drug. Nvidia’s record earnings reveal just 3 customers make up 30% of revenue.
Semaglutide API Market, Global Outlook and Forecast 2024-2030 – WhaTech
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used primarily for the treatment of type 2 diabetes and obesity. The growing …
Nutrigenomics Market Size, Share and Trends 2025 to 2034 – Precedence Research
… cancer, obesity, and cardiovascular diseases. North America has a … Obesity is a primary application area for nutrigenomics. The obesity …
ACTION Malaysia—perception and barriers to obesity management among people with …
The Awareness, Care, and Treatment in Obesity maNagement in the Asia Pacific region … 79%), cancer (72% vs. 68%), or stroke (68% vs. 74%) (Fig …
Patients struggle with lack of consistent coverage for popular weight-loss drugs
Many employers and insurers are scaling back coverage of Wegovy and Zepbound, and a key government program, Medicare, doesn’t cover the drugs for …
Diabetes Dialogue: News and Updates in Diabetes Care from February 2025 – HCPLive
… (Zepbound) single-dose vials and reduced pricing as well as the FDA … On February 25, 2025, Eli Lilly and Company announced the launch of 7.5 mg and 10 …
AbbVie enters obesity space with $2.3bn Gubra deal – Pharmaceutical Technology
… Zepbound (tirzepatide). According to a recently published report, GlobalData estimates that the obesity market will exceed $173.5bn by 2031 in the …
The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity
ABSTRACT
Background
The prevalence of obesity and related co-morbidities has reached epidemic proportions. Effective evidence-based treatment approaches are therefore important. Lifestyle intervention remains the mainstay of the treatment strategy to manage obesity. Increased evidence has also emerged regarding the efficacy of metabolic bariatric surgery (MBS) to induce significant and sustained weight loss while also reducing the progression of obesity-related co-morbidities for people living with obesity.
Aims & Methods
This article aims to bring together current evidence, guidance and best practice for the prevention and management of people living with overweight or obesity by means of lifestyle and behavioural intervention, as well as by MBS.
Result
Lifestyle intervention encompasses dietary strategies, physical activity and behavioural intervention. Discussion on MBS will focus on current indications, comparison between different MBS procedures, novel endoscopic techniques, potential complications and pre-operative management.
Plain Language Summary
The number of people living with excess weight and complications associated with being overweight is alarmingly quite high. Effective treatment approaches that are supported by clinical studies are therefore important. Lifestyle changes remain very important to manage excess weight. Increased evidence has also shown the benefits of weight loss surgery to produce significant weight loss which could be sustained, while also reducing the risk of developing medical conditions associated with excess weight. This article aims to bring together current evidence, guidance and best practice for the prevention and management of people living with excess weight by means of lifestyle and behavioural changes, as well as by weight loss surgery. Lifestyle intervention encompasses dietary strategies, physical activity and behavioural intervention. Discussion on weight loss surgery will focus on current criteria for suitability, comparison between different weight loss surgery procedures, new techniques, possible complications and appropriate management prior to weight loss surgery.